Search - tctmd.com

Displaying 581 - 600 of 1029

Sort: Relevancy | Date

News Daily News

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Michael O'Riordan

March 08, 2016

News Daily News

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

Michael O'Riordan

March 07, 2016

News Daily News

第 12 个月时女性的经导管主动脉瓣结局优于男性

Shelley Wood

February 23, 2016

News Daily News

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Shelley Wood

February 23, 2016

News Conference News CRT 2016

Health Apps, Bar Codes, and Big Data: The “Brave New World” of Medical Device Innovation

Shelley Wood

February 23, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Industry News

AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib

February 17, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Industry News

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

January 25, 2016

News Opinion Editor's Corner

The Gift of Data: Medical Journals Back Public Data Disclosure as Prerequisite for Publishing

Shelley Wood

January 24, 2016

News Daily News

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

Michael O'Riordan

January 18, 2016

News Daily News

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

Michael O'Riordan

January 18, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

News Industry News

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

January 14, 2016

News Industry News

Conavi Medical (formerly Colibri Technologies) announces FDA 510k clearance for its first product, the Foresight ICE System for Intracardiac Echocardiography

January 13, 2016

News Features

Possible Turf War Brewing Over Delivery of Acute Stroke Interventions

Todd Neale

December 28, 2015

News Industry News

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

December 07, 2015

News Daily News

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

L.A. McKeown

December 07, 2015

Advertisement

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

第 12 个月时女性的经导管主动脉瓣结局优于男性

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Health Apps, Bar Codes, and Big Data: The “Brave New World” of Medical Device Innovation

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

The Gift of Data: Medical Journals Back Public Data Disclosure as Prerequisite for Publishing

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

FDA Grants Go-Ahead for Low-Risk TAVR Study

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

Conavi Medical (formerly Colibri Technologies) announces FDA 510k clearance for its first product, the Foresight ICE System for Intracardiac Echocardiography

Possible Turf War Brewing Over Delivery of Acute Stroke Interventions

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content